Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi Post author: Post published:June 19, 2024 Post category:uncategorized A genetic treatment targeting the causal NRAS c.181C>A mutation in congenital melanocytic naevus. You Might Also Like Balancing health: diabetes and obesity increase risk of liver cancer relapse October 3, 2024 Red light therapy shown to significantly reduce blood sugar spikes, study finds February 23, 2024 Mental health factors key to recovery in older adults with hip fractures January 31, 2025